DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Sotrastaurin is an investigational drug.
There have been 6 clinical trials for Sotrastaurin. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Uveal Neoplasms, Melanoma, and Lymphoma, Mantle-Cell. The leading clinical trial sponsors are Novartis Pharmaceuticals, Array BioPharma, and James Blachly.
Recent Clinical Trials for Sotrastaurin
|Trial of AEB071 in Combination With BYL719 in Patients With Melanoma||Richard D. Carvajal||Phase 1|
|A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma||Array BioPharma||Phase 1/Phase 2|
|Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients||Novartis Pharmaceuticals||Phase 2|